Provider profile
Avid Bioservices.
Biologics CDMOs
Avid Bioservices describes cell line, process, analytical and liquid formulation development and CGMP drug substance manufacturing of monoclonal antibodies and recombinant proteins in CHO cells, from Phase I to commercial supply, plus conjugation of ADCs with non-potent payloads. It lists headquarters and manufacturing in Tustin, CA and an early-phase center in Costa Mesa, CA.
- Website
- avidbio.com (opens in a new tab)
- Sources reviewed
- November 3, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
- Analytical development and QC testing2,3
- Bioconjugation (ADC)7Limited to ADCs with non-potent payloads
- Cell line development4,5
- Formulation development6Liquid drug substance formulation; drug product formulation and fill/finish via external partners
- GMP drug substance manufacturing3,10Stated for the Tustin, CA facility
- Lyophilization6Stated as lyophilization cycle development for freeze-dried drug substance; drug product and fill/finish are via external partners
- Process development1
- Stability studies2,3
- Technology transfer11
Development experience
Development experience
Development stage
Locations
Locations
- Tustin, United States · Headquarters12
- Costa Mesa, United States · Manufacturing site4,11Early Phase Center of Excellence opened in 2026: cell line, process, analytical and formulation development and early-phase clinical manufacturing
- Tustin, United States · Manufacturing site4Mammalian drug substance manufacturing (clinical and commercial), process development and analytical labs
Quality and regulatory
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Available capacity, slot timing and scale for your next campaign
- Recent experience with your specific modality and expression system or chemistry
- Regulatory inspection history of the specific site that would manufacture your product
- Technology-transfer approach, timeline and who owns the resulting process knowledge
- Analytical and QC release testing done in-house versus subcontracted
- Quality agreement terms, batch-failure responsibility and change-order mechanics
Evidence and sources
Evidence and sources
- 1Biologics Process Development | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2Analytical Development Services for Biologics | CDMO | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3CGMP Manufacturing in Tustin, CA | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4US-Based Biologics CDMO Facilities | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5Early-Phase Biologics CDMO | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 6Formulation Development Services | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 7Antibody-Drug Conjugate Manufacturing | Avid (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 8Cell Line Development Services | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 9Tech Transfer & CMC Support | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 10Late-Phase Biologics CDMO | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 11About Avid Bioservices | US Biologics CDMO (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 12Contact Us | Avid Bioservices (opens in a new tab)Avid Bioservices · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.